Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04634617 · ClinicalTrials.gov registry record
Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors
A clinical trial of Endometrial Carcinoma and Malignant Uterine Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- 310
- Enrollment target
- 1
- Study location
NCT04634617 is a study of Endometrial Carcinoma and Malignant Uterine Neoplasm that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 310 participants, below the 379-participant average among 27 other Endometrial Carcinoma trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04634617, a study of Endometrial Carcinoma and Malignant Uterine Neoplasm, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 310 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies pelvic floor dysfunction and quality of life in uterine cancer survivors. Using questionnaires may help researchers learn more about the sexual function and quality of life in uterine cancer survivors.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2020-01-09 |
| Est. Completion | 2027-04-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04634617
The ClinicalTrials.gov registry entry for NCT04634617 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 310 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 379-participant average among 27 other Endometrial Carcinoma trials with a reported enrollment target (18% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Endometrial Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire Administration is the first listed.
NCT04634617 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04634617 about?
NCT04634617 is a clinical study titled "Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors". This trial studies pelvic floor dysfunction and quality of life in uterine cancer survivors. Using questionnaires may help researchers learn more about the sexual function and quality of life in uterine cancer survivors.
What is the current status of trial NCT04634617?
This trial is currently active not recruiting. The enrollment target is 310 participants. The study started on 2020-01-09. Estimated completion is 2027-04-11.
What conditions does trial NCT04634617 study?
This clinical trial studies the following conditions: Endometrial Carcinoma, Malignant Uterine Neoplasm, Uterine Corpus Sarcoma, Uterine Corpus Cancer.
What interventions are being tested in trial NCT04634617?
The interventions under investigation include: Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT04634617?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04634617 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia
RECRUITING · NA
-
Screening and Staging of Benign vs Malignant Pelvic Abnormalities
RECRUITING
-
Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding
RECRUITING
-
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
RECRUITING · Phase 3
-
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer
RECRUITING · Phase 1
-
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.